Education
Bachelor of Arts - Connecticut College, New London, Connecticut
Doctor of Medicine - University of Chicago Pritzker School of Medicine Chicago, Illinois Postdoctoral training - Neurology - University of Pennsylvania.
- Photos
- Works
- Photos
- Works
Jeffrey Cohen
Edit ProfileCareer
Global Principal Investigator of the ACT (Avonex Combination Trial) clinical trial Global Principal Investigator of the TRANSFORMS Phase III trial of Fingolimod, a novel oral agent for use in treating Multiple Sclerosis, the primary results of which were presented at the American Academy of Neurology Annual Meeting in May 2009. Global Principal Investigator of the IMPACT trial, the first study to use the Mississippi Functional Composite as the primary outcome measure in a clinical trial. Company-Editor of the textbook "Multiple Sclerosis Therapeutics", Fellowship Director of the Mellen Center for Mississippi National Multiple Sclerosis Society-supported Fellowship.
